Navigation Links
Dr. Kenneth L. Byrd Joins SteriFx Inc.
Date:7/7/2008

Brings 37 years of veterinary, regulatory and antimicrobial experience to

leader in non-toxic pathogen control solutions.

SHREVEPORT, La., July 7 /PRNewswire/ -- SteriFx Inc., a specialty chemical company that provides non-toxic antimicrobial solutions for food safety and other markets, has named Dr. Kenneth Byrd its National Accounts Director.

In his new role, Dr. Byrd will serve as the Company's regulatory and industry liaison. He will also work with its technical support team to assist poultry processing plants using SteriFx products, as well as troubleshoot pathogen problems. In addition, he will help grow the business by introducing the Company's antimicrobial solutions to potential customers.

One of those products is FreshFx antimicrobial solution, which is USDA- approved for use anywhere along the poultry processing line -- from scalder to post chill -- to control Salmonella, E. coli, Campylobacter, and Listeria. Since its approval as a processing aid in January 2003, FreshFx has been used to treat over 2.5 billion birds.

"We're excited to have Ken as a key member of SteriFx," says John R. Dankert, Ph.D., CEO of SteriFx. "He is a noted expert in the field of pathogen control, and we value his experience in all aspects of processing. His broad knowledge of the industry -- including the live side -- will permit us to more rapidly develop applications here."

Dr. Byrd graduated a Doctor of Veterinary Medicine (DVM) from Oklahoma State University, and ran his own veterinary practice before joining the USDA- FSIS, where he served as a Southwestern Region Supervisory Veterinary Medical Officer for 16 years.

His experience also includes 10 years as Director of Poultry Compliance Technology for Pilgrim's Pride, where he was pivotal in developing and implementing the HIMP program. In addition, Dr. Byrd has worked with several pathogen control companies, serving as an advisor to the USDA on proper chiller man
'/>"/>

SOURCE SteriFx Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
2. Kenneth A. Sylvia Named as New Publisher of Current Psychiatry
3. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
4. Leading Vaccine Expert Joins IAVI
5. Marshall Norris Joins NavigatorMD as Director of Business Development and Sales
6. Dr. Howard Epstein Joins Blue Cross as Medical Director for Commercial Operations and Clinical Design
7. Uroplasty Joins the Russell Microcap Index
8. Marc Andreessen Joins Facebook Board of Directors
9. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
10. Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor
11. Karen Haney Joins The Turning Point Group as Partner and Vice President of Client Services - Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... Nancy Chiaravalloti, PhD, of Kessler Foundation was named ... Jersey City, New Jersey. Dr. Chiaravalloti spoke on April ... the topic of "Treating Cognitive Deficits Following Neurological Illness ... be a part of the long legacy of the ... Chiaravalloti. "The field of rehabilitation research is a rewarding ...
(Date:4/24/2014)... scientists a better understanding of drug interactions, which are ... , When two or more medications are taken at ... effectiveness of the other. Similarly, one drug may ... are a major cause of illness and hospitalization. ... scope of drug studies in humans. Limits come ...
(Date:4/24/2014)... N.C. April 24, 2014 ,Take me out ... apple slices and kale chips. The more likely culprits ... Crackerjacks. , Unfortunately for children who play youth ... be contributing to weight problems, according to researchers at ... the current online edition of Childhood Obesity , ...
(Date:4/24/2014)... boring and irrelevant, could offer an alternative to heart ... Milena Furtado, and her team from the Australian Regenerative ... cell fibroblast is a close relative to a cardiomyocyte, ... In research published today in Circulation Research , ... cells due to their genetic program, and will aid ...
(Date:4/24/2014)... give than to receive at least if you,re an ... The study found that 15- and 16-year-olds who find pleasure ... members, are less likely to become depressed than those who ... money for themselves. , The researchers detail their findings in ... , The study focused on the ventral striatum, a brain ...
Breaking Medicine News(10 mins):Health News:Kessler Foundation scientist named 63rd Mendel Lecturer by St. Peter's University 2Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Take the bat, leave the candy 2Health News:Boring cells could hold the key to heart disease 2Health News:Study: Altruistic adolescents less likely to become depressed 2
... doing the rounds that global warming in the East ... A novel research by an international team places ... malaria’s spread, along with other factors like drug and ... University of Michigan theoretical ecologist Mercedes Pascual, has contributed ...
... with danger, is also the color of blood, signaling perpetuation ... of blood on a daily basis to cater to patients ... Sunderland have set the ball rolling, campaigning and urging people ... the run-up to Easter. ,Take the case of ...
... suggests that patients on the newer medications for diabetics ... spent between $920 and $1,760 less on annual total ... lead author and the Merrell Dow professor of pharmacy ... of medical records data on patients who took thiazolidinediones ...
... between widely used childhood medicines and the risk of developing ... allergies, expose the kids to pets and dirt early. The ... is known as the hygiene hypothesis. , It ... fields and farm animals, leaves people more susceptible to a ...
... review of several studies conducted on cancer-causing chemicals has ... babies as a consequence of exposure to organochlorines//. Pesticides ... such chemicals and may be passed on to humans ... it can be indirectly passed on to human beings ...
... cancer is one of the deadliest diseases in UK. Symptoms ... a need to rush to the loo//. ,Hence ... to increase awareness about prostate cancer. Prostate cancer kills 220 ... UK. ,Mr Campbell has won the support ...
Cached Medicine News:Health News:New Diabetic Drugs More Effective than Older Ones 2Health News:A Sneak Preview of Human’s Susceptibility to Auto Immune Disease, Allergy, Asthm 2Health News:Parents Concerned About Pesticide And Cancer Risk To Babies 2
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
(Date:1/14/2014)... New York , January 14, 2014 ... Closed System Transfer Devices (CSTD) for hazardous drugs, today announced ... for the fourth straight year.   ... for pharmacy technicians, pharmacists, nurses and other medical ...
(Date:1/14/2014)... Spark Therapeutics , a late-stage gene therapy company, has ... a Phase 3 study for inherited retinal dystrophies caused by mutations ... Marrazzo , is presenting this and other corporate updates today, at ... Francisco . Marrazzo said Spark was able to achieve its ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
... 9, 2011   Endo Pharmaceuticals (Nasdaq: ENDP ) today ... Conference on Tuesday, March 15, 2011 at 3:45 p.m. ET.  Dr. ... the company,s products and development programs. The presentation will ... www.endo.com under the investors section.   ...
... Accumetrics, Inc., a privately-held developer and marketer ... easy-to-use point-of-care system for measuring platelet reactivity to ... were recently published in The Annals of ... platelet reactivity as a new recommendation for preoperative ...
Cached Medicine Technology:2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery 22011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery 3
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol ... blood, chromosome, and histology smears. Our ... that rapidly penetrates cellular elements producing ... nuclear detail and unexcelled brilliance in ...
Wright-Giemsa Stain Solutions...
... Stain is ideal for stat, routine or ... smears and bone marrow. Our unique manufacturing ... yield excellent color intensity and morphological differentiation. ... in the Wright's staining procedure and includes ...
Medicine Products: